The total return over the past 12 months is -19.72% vs. +16.94% for the S&P 500. So far it's up -12.86% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (19.77%) | (60.12%) | (61.39%) | (46.74%) | (33.83%) | (36.70%) |
| Total Return CAGR | (19.72%) | (60.12%) | (61.39%) | (46.74%) | (33.84%) | (36.70%) |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
BioCardia, Inc. (BCDA)
| Year | Start price | End price | BCDA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.25 | $1.09 | (12.86%) | +14.51% | (27.37%) |
| 2025 | $2.18 | $1.25 | (42.62%) | +17.72% | (60.34%) |
| 2024 | $9.96 | $2.18 | (78.12%) | +24.89% | (103.01%) |
| 2023 | $94.05 | $9.96 | (89.41%) | +26.19% | (115.60%) |
| 2022 | $87.30 | $94.05 | +7.73% | (18.17%) | +25.90% |
| 2021 | $155.70 | $87.30 | (43.93%) | +28.74% | (72.67%) |
| 2020 | $165.60 | $155.70 | (5.98%) | +18.37% | (24.35%) |
| 2019 | $486.00 | $165.60 | (65.93%) | +31.22% | (97.15%) |
| 2018 | $951.75 | $486.00 | (48.94%) | (4.56%) | (44.38%) |
| 2017 | $5,250.90 | $951.75 | (81.87%) | +21.70% | (103.57%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
